Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Chapurlat

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Endocrinology and Metabolism|September 25, 2014
How to predict fragility fracture beyond 10 years? The OFELY studyE Sornay-Rendu, F Duboeuf, S Boutroy, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 8, 2004
Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention TrialR D Chapurlat, L Palermo, P Ramsay, et al.
Bone|June 23, 2004
Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatmentR D Chapurlat, P Hugueny, P D Delmas, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 23, 1997
Long-term effects of intravenous pamidronate in fibrous dysplasia of boneR D Chapurlat, P D Delmas, D Liens, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 16, 2002
Changes in biochemical markers of bone turnover in women treated with raloxifene: influence of regression to the meanR D Chapurlat, T Blackwell, D C Bauer, et al.
The Journal of Rheumatology|September 1, 1996
Dual energy X-ray absorptiometry in patients with lower limb reflex sympathetic dystrophy syndromeR D Chapurlat, F P Duboeuf, D Liens, et al.
The Journal of Clinical Endocrinology and Metabolism|September 11, 2001
Influence of smoking on the antiosteoporotic efficacy of raloxifeneR D Chapurlat, S K Ewing, D C Bauer, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 25, 2012
Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY studyP Garnero, E Sornay-Rendu, F Munoz, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 6, 2003
Incidence and risk factors for a second hip fracture in elderly women. The Study of Osteoporotic FracturesR D Chapurlat, D C Bauer, M Nevitt, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 8, 2000
Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS studyR D Chapurlat, P Garnero, G Bréart, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Endocrinology and Metabolism|September 25, 2014
How to predict fragility fracture beyond 10 years? The OFELY studyE Sornay-Rendu, F Duboeuf, S Boutroy, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 8, 2004
Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention TrialR D Chapurlat, L Palermo, P Ramsay, et al.
Bone|June 23, 2004
Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatmentR D Chapurlat, P Hugueny, P D Delmas, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 23, 1997
Long-term effects of intravenous pamidronate in fibrous dysplasia of boneR D Chapurlat, P D Delmas, D Liens, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 16, 2002
Changes in biochemical markers of bone turnover in women treated with raloxifene: influence of regression to the meanR D Chapurlat, T Blackwell, D C Bauer, et al.
The Journal of Rheumatology|September 1, 1996
Dual energy X-ray absorptiometry in patients with lower limb reflex sympathetic dystrophy syndromeR D Chapurlat, F P Duboeuf, D Liens, et al.
The Journal of Clinical Endocrinology and Metabolism|September 11, 2001
Influence of smoking on the antiosteoporotic efficacy of raloxifeneR D Chapurlat, S K Ewing, D C Bauer, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 25, 2012
Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY studyP Garnero, E Sornay-Rendu, F Munoz, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 6, 2003
Incidence and risk factors for a second hip fracture in elderly women. The Study of Osteoporotic FracturesR D Chapurlat, D C Bauer, M Nevitt, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 8, 2000
Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS studyR D Chapurlat, P Garnero, G Bréart, et al.
Pageof 4